YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

The Formulation and Dissolution Properties of Oral Sustained Release Sulindac Delivery System

설린닥의 경구용 지속성 제제설계 및 용출특성

  • Rhee, Gye-Ju (College of Pharmacy, Chungnam National University) ;
  • Park, Sun-Hee (College of Pharmacy, Chungnam National University) ;
  • Suh, Sung-Su (College of Pharmacy, Chungnam National University) ;
  • Whang, Sung-Joo (College of Pharmacy, Chungnam National University)
  • Published : 1997.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Sustained release matrix tablets, pellets, and coated pellets for the delivery of sulindac were prepared using cellulose derivatives at various ratios, and evaluated for the dis solution pattern. The release of sulindac, from matrix tablets prepared with low viscosity HPMC was relatively fast, and especially the tablets made of Metolose SM released all of sulindac within 1 hr. The release of drug from tablets made of other HPMC derivatives were retarded in the order of the following: Pharmacoat 645>Pharmacoat 606>Pharrnacoat 606+HPC-L>HPC-L. The most sustained release pattern was observed with the preparation of high viscous polymer. Metolose 90 SH. While release of sulindac, from matrix type pellet containing 10mg/cap of Metolose 90 SH or 60 SH was completed within 1 hr, a prolonged release formulation (30% in 1 hr) was obtained by the inclusion of EC. Pellets coated with HPMC showed a fast release pattern (${\geq}$ 80% within 2 hrs), whereas pellets coated with HPMC and EC (molar ratio 1 : 1) showed a sustained release pattern (${\geq}$ 80% in 12 hrs), vath the release from EC pellets being the most sustained. Fast (naked) and slow release pellets coated with EC, Metolose 60SH 50cps and propylene glycol. and enteric pellets coated with HPMCP 55 and Myvacet$^{\circledR}$ were prepared, and combined at various ratios for the assessment of dissolution pattern. The result indicates the possibility that the development of 24 hr sustained release delivery systems containing sulindac for oral administration could be achieved by means of combining sustained and fast release pellets at a proper portion.

Keywords

References

  1. Fed. Amer. Soc. Exp. Biol. v.31 Synthesis of a new anti-inflammatory agent cis-5-fluoro- 2- methyl-1-[p-(methylsulfinyl)-benzylidenyl]idene-3-acetic acid. Shen, T. Y.;Witzel, B. E.;Jones, H.;Linn, B. O.;McPhreson, J.;Greenwald, R.;Fordice, M.;Jacobs, A.
  2. Drugs v.16 Sulindac-a review of its pharmacological properties and therapeutic efficiency in rheumatic diseases Brogden, R. N.;Heel, R. C.;speight, T. M.;Avery, G. S.
  3. Martindale (The Extra Pharmacopoeia 30 edt.) v.34 Analgesics and Anti-inflammatory Agents Reynolds, J. E. F.
  4. Antiinflammatory Analgesics 4c v.8 no.3 MIMS Korea: Antirheumatic Cocabo, S. C.;Pharm, B. S.;Kin, P. T.
  5. Amer. Pharm Associ. v.13 Analytical profiles of drug substances-Sulindac. Plakogiannis, F. M.;McCauley, J. A.
  6. Scand. J. Rheumatol. v.Suppl 8 Sulindac vs phenylbutazone in the treatment of ankylosing spondylitis Godamski, M.;Singer-Bakker, H.;Braun, H. D.
  7. Scand. J. Rheumatol. v.Suppl 8 Controlled clinical study comparing a new antiinflammatory agent Sulindac (MK-231) with aspirin in the treatment of rheumatoid arthritis Highton, T. C.;Jeremy, R.
  8. Scand. J. Rheumatol. v.Suppl 8 Evaluation of Sulindac (MK-231) in acute gout Worthington, W. W.
  9. Amer. J. Gastroenterol. v.82 no.11 Gastroduodenal mucosa and dyspeptic symptons in arthritis partients during chronic nonsterioidal antiinflammatory drug use Larkai, E. N.;Smith, J. L.;Lidsky, M. D.;Graham, D. Y.
  10. Dig. Dis. Sci. v.28 no.2 Gastric bleeding and gastric secretion with Sulindac and naproxen Hunt, J. N.;Smith, J. L.;Jiang, C. L.
  11. J. Pharm. Sci. v.57 no.8 Drug release from compressed hydrophilic matrices Lapidus, H.;Lordi, N. G.
  12. J. Pharm. Sci. v.33 no.8 Some factors affecting the release of a water soluble drug from a compressed hydrophilic matrices Lapidus, H.;Lordi, N. G.
  13. J. Pharm. Sci. v.64 Linear drug release from laminated hydroxy propylcellulose-polyvinyl acetate films Borodkin, S. T.;Tucker, F. E.
  14. J. Pharm. Pharmacol. v.34 Moisture permeation mechanism of some aqueous-based film coats Okhamafe, A. O.;York, P.
  15. Controlled Drug Delivery Fundamentals and Applications(2nd ed) v.373 Design and fabrication of oral CR drug delivery systems Hui, H. W.;Robinson, J. R.;Lee, V. H. L.;J. R. Robinson(ed.);V. H. L. Lee(ed.)
  16. J. Pharm. Pharmacol. v.8 Sustained release of drug from ion exchange resins Chaudhry, N. C.;Saunders, L.
  17. J. Pharm. Sci. v.70 Sustained-release drug delivery system Ⅰ : Coated ion-exchange resin system for phenylpropanolamine and other drugs Raghunathan, Y.;Amsel, L.;Hinsvark, O.;Bryant, W.
  18. J. pharm. Sci. v.74 Preparation and evaluation of microencapsulated and coated ion-exchange resin beads containing theopylline Motycka, S.;Newth, C. J. L.;Nairn, J. G.
  19. Current. Therapeutic reserch. v.33 no.4 Controlled release dextromethorphan using advanced ion exchange technology Lilienfifld, M. D. L.;Edward, J. Z.
  20. U. S. Patent 3,916,899 Theeuwes, F.;Higuchi, T.
  21. Curr. Med. Res. Opi. v.8(Suppl.) Evaluation and design of ratecontrolled osmotic forms Theeuwes, F.
  22. Pharm. Int. v.5 Oral dosage form design : Status and goals of osmotic systems technology Theeuwes, F.
  23. J. Pharm. Sci. v.72 Elimentary osmotic pump for indomethacin Theeuwes, F.;Swanson, D.;Wong, P.;Bonsen, P.;Place, V.;Heimlich, K.;Kwan, K. C.
  24. Int. J. Pharm. v.16 Pharmacokinetic evaluation of osmotically controlled indomethacin delivery systems in man Rogers, J. D.;Lee, R. B.;Souder, P. R.;Ferguson, R. K.;Davies, R. O.;Theeuwes, F.;Kwan, K. C.
  25. Clinc. Pharmcol. Ther. v.32 Kinetics evaluation of osmotically controlled indomethacin delivery systems after repeated dosing Bayne, W.;Place, V.;Theeuwes, F.;Rogers, J. D.;Lee, R. B.;Davies, R. O.;Kwan, K. C.
  26. Drug Dev. Ind. Pharm. v.20 no.6 The development of an oral controlled release pellets formulation of diethylpropion hydrochloride Chetty, D. J.;Dangor, C. M.
  27. J. Pharm. Pharmacol. v.30 Solubility studies on ethylcellulose used in film coating Kent, D. J.;Rowe, R. C.
  28. Controlled Release Society, Inc. v.20 Chlorpheniramine maleate controlled release spheres Ⅰ, effect of ethylcellulose and dibutylsebacate levels Ortiz Labrador, A. R.;Ghaly, E. S.
  29. Int. J. Pharm. v.96 Application of low substituted hydroxypropylcellulose(L-HPC) in the production of pellets using extrusion/spheronization Kleinebudde, P.
  30. Int. J. Pharm. v.73 Factor affecting drug release from a pellet system coated with an aqueous colloidal dispersion Gilligan, C. A.;Po, A. L. W.
  31. J. Pharm. Sci. v.83 Mechanism of drug release from an acrylic polymer-wax matrix tablet Huang, H. P.;Mehta, S. C.;Radebaugh, G. W.;Fawzi, M. B.
  32. J. Controlled Release v.9 Gel-matrix systems exhibiting bimodal controlled release for oral delivery Sahr, A. C.;Britten, N. J.;Olanoff, L. S.;Badalamenti, J. N.
  33. J. Pharm. Sci. v.67 Sustanined release from inert wax matrices Ⅲ: Effect of povidone on tripelennamine hydrochloride release Dahkuri, A.;Butler, L. D.;DeLuca, P. P.
  34. J. Pharm. Sci. v.63 Release of a water-soluble drug from a wax matrix timed-release tablet Goodhart, F. W.;Mccoy, R. H.;Ninger, F. C.
  35. Drug. Dev. Ind. Pharm. v.15 hydroxypropylmethylcellulose sustained release technology Hogen, J. E.
  36. J. Controlled Release v.14 Influence of physicochemical properties of hydroxypropylmethylcellulose on naproxen release from sustained release matrix tablets Dahl, T. C.;Calderwood, T.;Bormeth, A.;Trimble, K.;Piepmeiei, E.
  37. Drug Dev. Ind. Pharm. v.11 Influence of hydroxypropyl methylcellulose and of manufacturing technics on in vitro performance of selected antacids Parab, P. V.;Nayak, M. P.;Ritschel, W. A.
  38. Int. J. Pharm. v.24 Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl methylcellulose matrices Ford, J. L.;Rubinstein, M. H.;Hogen, J. E.
  39. Int. J. Pharm. v.24 Propranolol hydrochloride aminophylline release from matrix tablets containing hydroxypropylmethylcellulose Ford, J. L.;Rubinstein, M. H.;Hogen, J. E.
  40. Drug Dev. Ind. Pharm. v.15 Hydroxypropylmethylcellulose sustained release technology Hogen, J. E.
  41. Int J. Pharmaceutics v.103 Effect of particle size and sorbed moiture on the compression behavior of some hydroxypropyl methylcellulose(HPMC) polymer Malamataris, S.;Karidas, T.;Goidas, P.
  42. J. Pharm. Sci. v.72 no.4 Sustained release of theophylline from hydroxypropylcellulose tablets Lakano, M.;Ohmori, N.;Ogata, A.;Sugimoto, K.;Tobino, Y.;Iwaoku, R.;Juni, K.
  43. Int. J. Pharm. v.90 Influence of ionic strength on matrix integrity and drug release from hydroxypropylcellulose compacts Johnson, J. L.;Holinej, J.;Williams, M. D.
  44. J. Pharm. Pharmacol. v.34 no.SUP. Release rate from sustained-release buccal tablets in man Hardy, J. G.;Kennerly, J. W.;Talyor, M. J.;Wilson, C. G.;Davis, S. S.
  45. Drug Dev. Ind. Pharm. v.16 Sustained release tablets of theophylline Sanghavi, N. M.;Kamath, P. R.;Amin, D. S.
  46. Pharm, Res. v.9 no.11 Relationship between polymer viscosity and drug release from a matrix system Cheong, L. W. S.;Heng, P. W. S.;Wong, L. F.
  47. Sustained and Controlled Release Drug Delivery System v.1 An overview of prolonged action drug dosage forms Ballard, G.;J. R. Robinson(ed.)
  48. A. Pharm. Tech Pub. v.29 The controlled release oral drug delivery opportunity, drug delivery systems, proceedings of an international conference Courson, J. D.
  49. Drug and the pharmaceutical sciences v.6 Sustained and Controlled Release Drug Delivery Systems Robinson, J. R.
  50. In oral sustained release formulations : design and evaluation Silber, B. M.;Cheung, W. K.;Yccobi, A.;A. Yacobi(ed.);E. Halperin-Walega(ed.)
  51. Drug Dev. Ind. Pharm. v.9 Oral controlled drug administation. Pharmacokinetic considerations Welling, P. G.
  52. Drug Dev. Ind. Pharm. v.20 no.7 Controlled-release matrix of acetaminophen-ethylcellulose solid dispersion Hernandez, J. I.;Ghaly, E. S.;Malave, A.;Marti, A.
  53. Int. J. Pharm. Tech. Prof Mfr. v.5 A review of cellulose ehters in hydrophilic matrices for oral controlled-release dosage forms Alderman, D. A.
  54. Int. J. Pharm. v.88 Swelling characteristics of hydrophilic matrices for controlled release new dimensionless Colombo, P.;Catellani, P. L.;Peppas, N. A.;Maggi, L.;Conte, U.
  55. Yakuzaigaku. v.39 no.1 Manufacture and examination of apparatus for drug release from suppositories Muranishi, S.;Okubo, Y.;Sezaki, H.
  56. J. Pharm. Sci. v.58 Release rates of salicylates from cocoa butter I Weiss, A. L.;Sciarrone, B. J.
  57. Yakhak Hoeji v.28 no.3 Effect of diethylphthalate on the release of salicylci acid from ethylcellulose film Lee, S. Y.;Shin, S. C.;Lee, M. H.;Shim, C. K.
  58. Chem Pharm. Bull. v.23 no.1 Inclusion complexes of β-cyclodextrin with tranquilizing drugs phenothiazines in aqueous solution Otagiri, M.;Uekama, K.;Ikeda, K.
  59. Chem Pharm. Bull. v.23 no.1 Inclusion complexes of β-cyclodextrin with antiinflammatory drugs fenamates in aqueous solution Ikeda, K.;Uekama, K.;Otagiri, M.